ALPMY OTC
Astellas Pharma Inc.
1W: -4.3%
1M: -5.3%
3M: +5.1%
YTD: +7.5%
1Y: +29.9%
3Y: +6.2%
5Y: -7.3%
$14.32
-0.12 (-0.83%)
Weekly Expected Move ±3.8%
$13
$14
$14
$15
$15
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$2,268B
Revenue
+18.6% YoY
$309B
Net Income
+509.1% YoY
$516B
Free Cash Flow
+227.6% YoY
70.7%
Gross Margin
17.6%
Op. Margin
9.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE18.4%
ROA8.9%
ROIC19.1%
Valuation
P/E11.0
P/B2.1
EV/EBITDA0.0
Leverage
Debt/Equity0.13
Current Ratio1.17
Interest Cov.29.8x
Quality Scores
Piotroski F8/9
Altman Z—
Beneish M-2.42